Medicine
Plavix 300 mg tablet
Plavix 300 mg tablet is a prescription medicine containing Clopidogrel for oral use, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F).
Key facts
- Active ingredient (INN)
- Clopidogrel
- Brand
- Plavix
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 3 blister pack
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturer
- Sanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC03 Clopidogrel
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2009
- Identifiers
- RxCUI 213169, 309362, 749196 +1DailyMed set ID de8b0b67-eb25-4684-83b5-7ad785314227NDC 0024-1332Application NDA020839
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 0024-1332-30 | Sanofi-Aventis | 13 July 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clopidogrel 300 mg tablet.
Other strengths and forms of Clopidogrel
Clinical summary
Clopidogrel is a P2Y12 platelet inhibitor indicated for acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), among other approved uses. MedsAcross supplies Clopidogrel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClopidogrelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Plavix prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Clopidogrel Zentiva (previously Clopidogrel Winthrop): European public assessment report (EPAR) · European Medicines Agency
- Iscover: European public assessment report (EPAR) · European Medicines Agency
Need Plavix 300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.